Timmis A, Vardas P, Townsend N et al (2022) European society of cardiology: cardiovascular disease statistics 2021. Eur Heart J 43(8):716–799

Article  PubMed  Google Scholar 

Zhao D, Liu J, Wang M et al (2019) Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol 16(4):203–212

Article  PubMed  Google Scholar 

Liu H-H, Cao Y-X, Jin J-L et al (2020) Association of lipoprotein(a) levels with recurrent events in patients with coronary artery disease. Heart 106(16):1228–1235

Article  PubMed  Google Scholar 

Verma S, Bain SC, Buse JB et al (2019) Occurence of first and recurrent major adverse cardiovascular events with liraglutide treatment among patients with type 2 diabetes and high risk of cardiovascular events: a post hoc analysis of a randomized clinical trial. JAMA Cardiol 4(12):1214–1220

Article  PubMed  Google Scholar 

Hoogeveen RC, Ballantyne CM (2021) Residual cardiovascular risk at low LDL: remnants, lipoprotein(a), and inflammation. Clin Chem 67(1):143–153

Article  PubMed  Google Scholar 

Cannon CP, Blazing MA, Giugliano RP et al (2015) Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 372(25):2387–2397

Article  CAS  PubMed  Google Scholar 

Sabatine MS, Giugliano RP, Keech AC et al (2017) Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 376(18):1713–1722

Article  CAS  PubMed  Google Scholar 

Nguyen SV, Nakamura T, Kugiyama K (2014) High remnant lipoprotein predicts recurrent cardiovascular events on statin treatment after acute coronary syndrome. Circ J 78(10):2492–2500

Article  CAS  PubMed  Google Scholar 

Duarte Lau F, Giugliano RP (2022) Lipoprotein(a) and its significance in cardiovascular disease: a review. JAMA Cardiol 7(7):760–769

Article  PubMed  Google Scholar 

Gudbjartsson DF, Thorgeirsson G, Sulem P et al (2019) Lipoprotein(a) concentration and risks of cardiovascular disease and diabetes. J Am Coll Cardiol 74(24):2982–2994

Article  CAS  PubMed  Google Scholar 

Liu H-H, Cao Y-X, Jin J-L et al (2020) Predicting cardiovascular outcomes by baseline lipoprotein(a) concentrations: a large cohort and long-term follow-up study on real-world patients receiving percutaneous coronary intervention. J Am Heart Assoc 9(3):e014581

Article  PubMed  PubMed Central  Google Scholar 

Cui K, Yin D, Zhu C et al (2022) Impact of Lipoprotein(a) concentrations on long-term cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a large cohort study. Nutr Metab Cardiovasc Dis 32(7):1670–1680

Article  CAS  PubMed  Google Scholar 

Reyes-Soffer G, Ginsberg HN, Berglund L et al (2022) Lipoprotein(a): a Genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American heart association. Arterioscler Thromb Vasc Biol 42(1):e48–e60

Article  CAS  PubMed  Google Scholar 

Kronenberg F, Mora S, Stroes ESG et al (2022) Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European atherosclerosis society consensus statement. Eur Heart J. https://doi.org/10.1093/eurheartj/ehac361

Article  PubMed  PubMed Central  Google Scholar 

Catapano AL, Tokgözoğlu L, Banach M et al (2023) Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: a survey among the lipid clinics network. Atherosclerosis 370:5–11

Article  CAS  PubMed  Google Scholar 

Li J-J, Ma C-S, Zhao D et al (2022) Lipoprotein(a) and cardiovascular disease in Chinese population: a Beijing heart society expert scientific statement. JACC Asia 2(6):653–665

Article  PubMed  PubMed Central  Google Scholar 

Kavousi M, Leening MJG, Nanchen D et al (2014) Comparison of application of the ACC/AHA guidelines, adult treatment panel iii guidelines, and European society of cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA 311(14):1416–1423

Article  PubMed  Google Scholar 

Saeed A, Sun W, Agarwala A et al (2019) Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: the atherosclerosis risk in communities study. Atherosclerosis 282:52–56

Article  CAS  PubMed  Google Scholar 

Waldeyer C, Makarova N, Zeller T et al (2017) Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium. Eur Heart J 38(32):2490–2498

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Jin J-L, Cao Y-X et al (2020) Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study. Cardiovasc Diabetol 19(1):111

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang L, Gao P, Zhang M et al (2017) Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA 317(24):2515–2523

Article  PubMed  PubMed Central  Google Scholar 

Jin J-L, Cao Y-X, Zhang H-W et al (2019) Lipoprotein(a) and cardiovascular outcomes in patients with coronary artery disease and prediabetes or diabetes. Diabetes Care 42(7):1312–1318

Article  CAS  PubMed  Google Scholar 

Zhang Y, Jin J-L, Cao Y-X et al (2020) Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study. J Transl Med 18(1):373

Article  CAS  PubMed  PubMed Central  Google Scholar 

AD Association (2022) 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care 45(Suppl 1):S17–S38

Google Scholar 

He J, Bian X, Song C et al (2022) High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study. Cardiovasc Diabetol 21(1):156

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hess CN, Clare RM, Neely ML et al (2017) Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome. Am Heart J 187:194–203

Article  PubMed  Google Scholar 

Smolina K, Wright FL, Rayner M et al (2012) Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010. Circ Cardiovasc Qual Outcomes 5(4):532–540

Article  PubMed  Google Scholar 

Feng W, Hendry RM, Adams RJ (2010) Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients. Neurology 74(7):588–593

Article  PubMed  Google Scholar 

Kaasenbrood L, Boekholdt SM, van der Graaf Y et al (2016) Distribution of estimated 10-year risk of recurrent vascular events and residual risk in a secondary prevention population. Circulation 134(19):1419–1429

Article  PubMed  Google Scholar 

Gencer B, Kronenberg F, Stroes ES et al (2017) Lipoprotein(a): the revenant. Eur Heart J 38(20):1553–1560

Article  CAS  PubMed  Google Scholar 

Schwartz GG, Ballantyne CM, Barter PJ et al (2018) Association of lipoprotein(a) with risk of recurrent ischemic events following acute coronary syndrome: analysis of the dal-outcomes randomized clinical trial. JAMA Cardiol 3(2):164–168

Article  PubMed  Google Scholar 

Gencer B, Rigamonti F, Nanchen D et al (2019) Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes. Eur J Clin Invest 49(7):e13117

Article  PubMed  Google Scholar 

Sun H, Saeedi P, Karuranga S et al (2022) IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119

Article  PubMed  Google Scholar 

Huth C, Bauer A, Zierer A et al (2020) Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease-a comparison in the MONICA/KORA study. Cardiovasc Diabetol 19(1):32

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tolbus A, Mortensen MB, Nielsen SF et al (2017) Kringle IV type 2, not low lipoprotein(a), as a cause of diabetes: a novel genetic approach using SNPs associated selectively with lipoprotein(a) concentrations or with kringle IV type 2 repeats. Clin Chem 63(12):1866–1876

Article  CAS  PubMed  Google Scholar 

Liu H-H, Cao Y-X, Li S et al (2018) Impacts of prediabetes mellitus alone or plus hypertension on the coronary severity and cardiovascular outcomes. Hypertension 71(6):1039–1046

Article  CAS  PubMed  Google Scholar 

Lawler PR, Bhatt DL, Godoy LC et al (2021) Targeting cardiovascular inflammation: next steps in clinical translation. Eur Heart J 42(1):113–131

Article  CAS  PubMed  Google Scholar